Skip to main content

Solventum Corp company profile

  • SOLV · NYSE
  • Medical devices
  • Health Care Technology
  • S&P 500
$89.08+0.30%Close 13 Nov 2026

About Solventum Corp

Solventum Corporation is a global healthcare company that develops, manufactures, and commercializes medical and dental products and healthcare software. Its MedSurg segment, which accounted for 57.9% of 2025 total sales, offers negative pressure wound therapy, advanced wound dressings, surgical supplies, sterilization assurance, and temperature management solutions. Dental Solutions, at 16.2% of 2025 total sales, provides dental and orthodontic products including brackets, aligners, and restorative materials. Health Information Systems, at 16.3% of 2025 total sales, supplies healthcare systems with documentation, coding, and revenue cycle software. The company sells principally to hospitals, physicians, and other healthcare providers, with sales in over 90 countries.

A summary of the business section of the company's latest annual report, filed 27 Feb 2026.

Company facts

TickerSOLV · NYSE
SectorMedical devices
IndustryHealth Care Technology
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1964738
Latest annual report10-K, filed 27 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Bryan HansonChief Executive Officer · Director124K · < 1%Option exercise, 1 Sep 2026
Wayde McMillanChief Financial Officer43.5K · < 1%Shares withheld for tax, 13 May 2026
Amy LanducciChief Information Officer37.5K · < 1%Option exercise, 13 May 2026
Marcela KirbergerChief Legal Affairs Officer11.0K · < 1%Shares withheld for tax, 13 May 2026
Chris BarryExecutive Vice President9.2K · < 1%Option exercise, 13 May 2025
Carrie S. CoxDirector5.1K · < 1%Option exercise, 30 Apr 2026
Amy A. WendellDirector5.0K · < 1%Option exercise, 30 Apr 2026
Elizabeth A. MilyDirector3.6K · < 1%Option exercise, 30 Apr 2026
Susan D. DeVoreDirector3.6K · < 1%Option exercise, 30 Apr 2026
Shirley EdwardsDirector3.6K · < 1%Option exercise, 30 Apr 2026
Glenn A. EisenbergDirector3.6K · < 1%Option exercise, 30 Apr 2026
Dr. Bernard A. Harris Jr.Director3.6K · < 1%Option exercise, 30 Apr 2026
Karen J. MayDirector3.6K · < 1%Option exercise, 30 Apr 2026
John H. WeilandDirector3.6K · < 1%Option exercise, 30 Apr 2026
Darryl L. WilsonDirector3.6K · < 1%Option exercise, 30 Apr 2026
Wilcox Mary TChief Accounting Officer—Option exercise, 13 May 2026
Harrington Paul SChief Supply Chain Officer—Option exercise, 13 May 2026
Gomez Tammy LChief Human Resources Officer—Shares withheld for tax, 13 May 2026
ALBAN CARLOSDirector—Option exercise, 30 Apr 2026
Solventum CorpChief Legal Affairs Officer—Option exercise, 1 Dec 2024

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

SOLV in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.